Mr. Michael J Dolan, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 4384 Lakeville Rd, Geneseo, NY 14454 Phone: 585-243-2020 Fax: 585-243-1372 |
Geneseo Family Eye Care, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4384 Lakeville Rd, Geneseo, NY 14454 Phone: 585-243-2020 |
Wendel Vision Care Pllc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4235 Veteran Dr, Geneseo, NY 14454 Phone: 614-570-4015 |
Dr. Michelle Di Tusa, OD Optometrist Medicare: Medicare Enrolled Practice Location: 4235 Veteran Dr, Geneseo, NY 14454 Phone: 585-243-3940 |
Dr. Danielle Lynne James, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4235 Veteran Dr, Geneseo, NY 14454 Phone: 585-243-4004 Fax: 585-243-4009 |
Michelle Ditusa, Od Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4235 Veteran Dr, Geneseo, NY 14454 Phone: 585-243-3940 |
News Archive
HHS Secretary Kathleen Sebelius today announced 63 awards totaling more than $7.6 million to help states recruit new health care clinicians and alleviate their debt burden. The funds are part of the $500 million appropriated to HHS' Health Resources and Services Administration (HRSA) by the American Recovery and Reinvestment Act (ARRA) to address workforce shortages and encourage diversity in the health professions.
Biomedical imaging has revolutionized medicine, granting doctors a window into miniscule molecular and cellular processes inside the body. An EU-funded project helped to expand the view, developing innovative radiochemistry concepts and techniques that could lead to earlier diagnosis of diseases - saving lives.
People carrying the germ-line MSH6 mutation are at high risk by age 80 years for colorectal and endometrial cancers and any cancer associated with Lynch syndrome, according to a new study published online December 22 in the Journal of the National Cancer Institute.
New software 'hearing dummies' are part of cutting-edge research that promises to revolutionise the diagnosis and treatment of hearing impairments.
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced that aggregate revenue of its partner companies for the three months ended June 30, 2010 was $91.6 million, up 47% from $62.3 million for the same partner companies in the same period of 2009. For the six months ended June 30, 2010, the aggregate partner company revenue was $176.9 million, up 45% from $121.8 million for the same partner companies for the same period of 2009.
› Verified 9 days ago